Saxenda is an FDA-approved prescription obesity medication that reduces appetite and slows gastric emptying by mimicking the body's naturally occurring hormone GLP-1. It is administered as daily subcutaneous injections, starting at a low dose and gradually increasing; it is only effective when used in conjunction with a balanced diet and exercise program.
Who is it suitable for? It is generally prescribed to people who meet the following criteria: Those with a Body Mass Index (BMI) of 30 or higher (obesity); those with a BMI between 27 and 30 who have at least one additional weight-related condition such as hypertension, type 2 diabetes, or high cholesterol.